We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

194 hedge funds and large institutions have $4.37B invested in NEVRO CORP. in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 72 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less funds holding

Funds holding: 207194 (-13)

13% less call options, than puts

Call options by funds: $32.9M | Put options by funds: $37.7M

15% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 72

24% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 46

31% less capital invested

Capital invested by funds: $6.36B → $4.37B (-$1.99B)

Holders
194
Holders Change
-13
Holders Change %
-6.28%
% of All Funds
3.4%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
61
Reduced
72
Closed
46
Calls
$32.9M
Puts
$37.7M
Net Calls
-$4.8M
Net Calls Change
-$9.11M

NVRO Hedge Fund Activity: Q3 2021 in Review

194 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2021, worth a combined $4.37B — down 31% from $6.36B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of NVRO and 35 opened new positions — a net loss of 11 holders — while 72 trimmed existing stakes and 61 added.

The largest buyer was Jackson Square Partners, adding an estimated $127M. The largest seller was Fred Alger Management, cutting an estimated $165M.

  • 194 institutional investors held NEVRO CORP. (NVRO) as of Q3 2021, down from 207 in Q2 2021.
  • Funds reported $4.37B of NEVRO CORP. stock for Q3 2021, down 31% quarter-over-quarter.
  • 35 funds opened new NEVRO CORP. positions in Q3 2021 and 46 closed out, a net change of -11 holders.
  • The largest NEVRO CORP. buyer in Q3 2021 was Jackson Square Partners, an estimated $127M added.
  • The largest NEVRO CORP. seller in Q3 2021 was Fred Alger Management, an estimated $165M sold.

Based on aggregated 13F filings for Q3 2021.